Boston Bio Systems Limited (BOM:531458)

Boston Bio Systems Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.43	0.53	0.53	0.54	0.55
Trading Asset Securities	-	1.45	1.45	1.45	1.45
Cash & Short-Term Investments	0.43	1.98	1.98	1.99	2
Cash Growth	-78.28%	-	-0.61%	-0.44%	-0.47%
Accounts Receivable	28.78	28.78	28.78	28.78	28.78
Other Receivables	-	0.19	0.19	0.19	0.19
Receivables	29.03	45.77	45.77	29.23	29.23
Inventory	1.45	-	-	-	-
Other Current Assets	60.19	-	-	16.55	16.55
Total Current Assets	91.1	47.75	47.75	47.76	47.77
Long-Term Deferred Tax Assets	0	0	0	0	0
Other Long-Term Assets	57.94	57.94	57.94	-	-
Total Assets	149.04	105.69	105.69	105.7	105.71
Accounts Payable	33.07	30.48	30.48	29.61	30.48
Accrued Expenses	-	0.08	0.07	0.35	0.34
Short-Term Debt	-	-	-	7.5	7.5
Current Portion of Long-Term Debt	8.48	7.5	7.5	-	-
Current Income Taxes Payable	-	-	-	0	0
Current Unearned Revenue	-	-	-	0.87	-
Other Current Liabilities	2.52	1.95	0.55	0.26	0.26
Total Current Liabilities	44.06	40.01	38.6	38.59	38.58
Long-Term Debt	45.93	1.16	1.16	1.16	1.16
Other Long-Term Liabilities	0	-	-	-	-
Total Liabilities	89.99	41.17	39.76	39.75	39.74
Common Stock	70.02	70.02	70.02	70.02	70.02
Retained Earnings	-10.98	-5.5	-4.1	-4.08	-4.06
Shareholders' Equity	59.05	64.52	65.93	65.95	65.97
Total Liabilities & Equity	149.04	105.69	105.69	105.7	105.71
Total Debt	54.41	8.66	8.66	8.66	8.66
Net Cash (Debt)	-53.98	-6.69	-6.69	-6.67	-6.67
Net Cash Per Share	-7.69	-0.96	-0.91	-0.95	-0.95
Filing Date Shares Outstanding	7.01	7	7	7	7
Total Common Shares Outstanding	7.01	7	7	7	7
Working Capital	47.04	7.74	9.15	9.17	9.19
Book Value Per Share	8.43	9.21	9.41	9.42	9.42
Tangible Book Value	59.05	64.52	65.93	65.95	65.97
Tangible Book Value Per Share	8.43	9.21	9.41	9.42	9.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.